India's Drug-Industry Woes No Deterrence To More Than Doubled Market
This article was originally published in PharmAsia News
Executive Summary
Despite its U.S. FDA, regulatory and other problems, India's pharmaceutical market is expected to more than double its value over the next seven years, from $21 billion to $56 billion.